Management of R&D portfolios is the 2nd ranked internal strategy within the pharmaceutical industry, and many CFO’s expect M&A activity to continue to increase in the coming year. 

This conference provides financial and accounting teams with the strategies, best practices and financial guidance for ensuring winning deal-making endeavors.  CPE credits are available for this in-depth course, which convenes over 100 executives each year.

Co-located with CBI's Forum on Strategic Pipeline Planning 

Other CBI Financial Series Events

Hear what some of our previous attendees had to say:

“Great content and presentations – Relevant real world examples.”
– 2009 Attendee, Dave Levi, Director of Technical Accounting, Bristol Myers Squibb

“Outstanding content presented in a real world manner, focusing on recent transactions and events.”
– 2009 Attendee, Henry Huseby, Associate Director, Technical Accounting, Bristol-Myers Squibb

“The conference was very informative.”
– 2009 Attendee, Tom Hess, Chief Financial Officer, Yaupon Therapeutics

“Interesting to know what others are doing in the bio/Pharma industry.”
– 2009 Attendee, Steve Kyriakos, Executive Director of Accounting and Finance, Morphotek

“Good industry insights from people who deal with the issues first hand.”
– 2009 Attendee, Andreas Chrystostomous, Managing Director, Duff & Phelps

“The presenters covered all the topics thoroughly and took the time to answer tailored questions from each session.”
– 2009 Attendee, Lauren Riker, Senior Director of Financial Reporting, Ikaria

“Content was timely and on point!”
– 2008 Attendee, Justin Vogel, Corporate Controller, Pharmacopeia

“Great course!  The content was extremely timely and speakers were excellent.”
– 2008 Attendee, Dan Rudio, Director of Financial Reporting, Endo Pharmaceuticals

Sponsors/Exhibitors:

For more information or to register, please contact the Center for Business Intelligence toll free by phone at 1-800-817-8601 or via e-mail at cbireg@cbinet.com.